Xueyuan Wang

发表

Pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on N-benzylpyrimidin-4-amine derivatives as VCP/p97 inhibitors

Yongqiang Zhu, Chenxi Gu, Yonglei Zhang, 2020, Medicinal Chemistry Research.

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib

Meng Lei, Yongqiang Zhu, Jianyong Li, 2021, Cell Death & Disease.

Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.

Hailong Liu, Yongqiang Zhu, Yonglei Zhang, 2021, Bioorganic & medicinal chemistry.

Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.

Meng Lei, Yongqiang Zhu, Jia Liu, 2019, Bioorganic & medicinal chemistry.

Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studies.

Meng Lei, Yongqiang Zhu, Jing Shi, 2018, Bioorganic & medicinal chemistry.

Targeting cancer cells with biotin-dendrimer conjugates.

T. Xu, Wenjun Yang, Yiyun Cheng, 2009, European journal of medicinal chemistry.

Trifluoromethyl aryl sulfonates (TFMS): An applicable trifluoromethoxylation reagent

Chengjian Zhu, Jian Shen, Meng Lei, 2019, Tetrahedron Letters.

Facile synthesis of 5 nm NaYF₄:Yb/Er nanoparticles for targeted upconversion imaging of cancer cells.

Yuxiu Sun, J. Huo, Yan Li, 2016, Talanta.

Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.

Xiaomin Wang, T. Xu, Yiyun Cheng, 2007, Journal of pharmaceutical sciences.

In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma

E. Izumchenko, Meng Lei, Yongqiang Zhu, 2020, Aging.

Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance

Meng Lei, Xiaoqing Du, Yongqiang Zhu, 2019, Drug delivery.

Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma.

Hailong Liu, Wen Zhang, Meng Lei, 2021, Bioorganic & medicinal chemistry.

Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors.

Jian Shen, Meng Lei, Xiaoqing Du, 2019, Bioorganic & medicinal chemistry.

Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.

Meng Lei, Yongqiang Zhu, Xueyuan Wang, 2022, Bioorganic & medicinal chemistry.

Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma

Xueyuan Wang, Jie Xiong, Jie Jiang, 2022, Frontiers in Immunology.

Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.

Meng Lei, Yongqiang Zhu, Jia Liu, 2019, Organic & biomolecular chemistry.

Design, synthesis, SAR discussion, in vitro and in vivo evaluation of novel selective EGFR modulator to inhibit L858R/T790M double mutants.

Meng Lei, Yongqiang Zhu, Hao Cheng, 2017, European journal of medicinal chemistry.

Therapeutic effect of multifunctional celastrol nanoparticles with mitochondrial alkaline drug release in breast cancer

Yongqiang Zhu, Hui Sun, Liefeng Zhang, 2023, Materials Today Advances.

Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma.

Wen Zhang, Meng Lei, Yongqiang Zhu, 2023, European journal of medicinal chemistry.

Co-delivery of paclitaxel and gemcitabine via a self-assembling nanoparticle for targeted treatment of breast cancer

Meng Lei, Xiaoqing Du, Yongqiang Zhu, 2019, RSC advances.

Design, synthesis and evaluation of a series of potential prodrugs of a Bruton’s tyrosine kinase (BTK) inhibitor

Xueyuan Wang, Min Liao, Xiaojing Lan, 2023, Frontiers in Pharmacology.

KPT‐330 and Y219 exert a synergistic antitumor effect in triple‐negative breast cancer through inhibiting NF‐κB signaling

Meng Lei, Jing Shi, Jia Wang, 2023, FEBS open bio.

Meng Lei, Yongqiang Zhu, Jing Shi, 2018, Bioorganic & medicinal chemistry.

Targeting cancer cells with biotin-dendrimer conjugates.

T. Xu, Wenjun Yang, Yiyun Cheng, 2009, European journal of medicinal chemistry.

Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance

Meng Lei, Xiaoqing Du, Yongqiang Zhu, 2019, Drug delivery.

Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment.

Liefeng Zhang, Xueyuan Wang, Tianyu Zhang, 2024, Biomaterials advances.